Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/14/1994 | EP0628640A1 Simultaneous amplification of multiple targets |
12/14/1994 | EP0628639A1 Reconstituted human antibody against human interleukin 6 receptor |
12/14/1994 | EP0628638A2 Process for preparing 2-amino-3-hydroxy acids |
12/14/1994 | EP0628636A1 Transgenic plants exhibiting modified carbohydrate metabolism |
12/14/1994 | EP0628635A1 Process for generating male sterile plants |
12/14/1994 | EP0628634A2 Process for preparing serine hydroxymethyltransferase |
12/14/1994 | EP0628633A1 Recombinant herpes simplex gB-gD vaccine |
12/14/1994 | EP0628632A1 Protein protease inhibitors from streptomyces |
12/14/1994 | EP0628631A1 A phosphatidylethanolamine binding protein derived from a human glioblastoma cell line and DNA encoding it |
12/14/1994 | EP0628572A2 DNA originating in non-A non-B hepatitis virus gene and constituting polypeptide |
12/14/1994 | EP0628568A2 Method for the immobilisation of nucleic acids |
12/14/1994 | EP0628084A1 Monoclonal antibodies and anti-idiotypic antibodies to hepatitis c virus |
12/14/1994 | EP0628083A1 Heterologous gene expression in lactococcus, and the expression products therefrom |
12/14/1994 | EP0628082A1 Agrobacterium strains capable of site-specific recombination |
12/14/1994 | EP0628081A1 CLONING AND EXPRESSION OF THE EXO-POLYGALACTURONASE GENE FROM $i(ASPERGILLUS) |
12/14/1994 | EP0628080A1 Cloning and expression of xylanase b |
12/14/1994 | EP0628079A1 Hepatitis c virus peptides |
12/14/1994 | EP0628078A1 Multivalent single chain antibodies |
12/14/1994 | EP0628077A1 Humanised antibodies directed against a33 antigen |
12/14/1994 | EP0628076A1 PRODUCTION OF MONOCLONAL RECOMBINANT ANTIBODIES WITHOUT THE USE OF HYBRIDOMAS BY $i(IN VITRO) SPLEEN FRAGMENT CULTURE COMBINED WITH ISOTHERMAL SELF-SUSTAINED SEQUENCE REPLICATION OF RNA |
12/14/1994 | EP0628075A1 Endo-1,4-beta-d-glucanase |
12/14/1994 | EP0628074A1 $i(IN VITRO) ACTIVATION OF CYTOTOXIC T CELLS |
12/14/1994 | EP0628055A1 Modified tcf |
12/14/1994 | EP0628054A1 Car receptors and related molecules and methods |
12/14/1994 | EP0628053A1 Hepatitis e virus peptide antigens and antibodies |
12/14/1994 | EP0628051A1 Applications of fluorescent n-nucleosides and fluorescent structural analogs of n-nucleosides |
12/14/1994 | EP0627934A1 Early antigen for autoimmune diabetes |
12/14/1994 | EP0627932A1 Novel antibody construct |
12/14/1994 | EP0627923A1 Therapeutic domains of von willebrand factor |
12/14/1994 | EP0520039B1 A process for distinguishing nucleic acids on the basis of nucleotide differences |
12/14/1994 | EP0471030B1 Glycoprotein hormone receptor molecules |
12/14/1994 | EP0380607B1 Anti-idiotype antibodies to anti-human high molecular weight-melanoma associated antigen |
12/14/1994 | EP0371112B1 Isolation and characterisation of genes resistant to anthracycline antibiotics |
12/14/1994 | EP0101681B1 Antibody to a mediator activity composition and its use in a pharmaceutical composition |
12/14/1994 | CN1096223A Vaccines raising immunological response against viruses causing porcing respiratory and reproductive diseases |
12/14/1994 | CN1026994C Kluyveromyces as a host strain |
12/13/1994 | US5373090 Aprotinin analogues and a process for the production thereof |
12/13/1994 | US5372943 Lipid microemulsions for culture media |
12/13/1994 | US5372933 Antibody-polypeptide immunocomplex |
12/13/1994 | US5372928 Hepatitis C virus isolates |
12/13/1994 | US5372809 Antigenic matrix metalloproteinase peptides |
12/13/1994 | US5372808 Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect |
12/11/1994 | CA2125536A1 Genetic selection, by means of signal transduction in microorganisms, of proteins which are capable of ligand binding |
12/09/1994 | CA2125008A1 Peptide and dnas encoding it |
12/08/1994 | WO1994028424A1 Method for selection of biologically active peptide sequences |
12/08/1994 | WO1994028413A1 Plasmodium vivax blood stage antigens, antibodies, and diagnostic assays |
12/08/1994 | WO1994028391A1 Ligands for flt3 receptors |
12/08/1994 | WO1994028180A2 Fruit with modified nadp-linked malic enzyme activity |
12/08/1994 | WO1994028178A1 In-situ hybridization probes for identification and banding of specific human chromosomes and regions |
12/08/1994 | WO1994028176A2 Bc200 rna, probes therefor and use thereof |
12/08/1994 | WO1994028175A1 Direct detection of expanded nucleotide repeats in the human genome |
12/08/1994 | WO1994028174A1 Nucleic acid probes for bacteria of the genus legionella |
12/08/1994 | WO1994028173A1 Association peptides |
12/08/1994 | WO1994028172A1 Probes for detection of the fragile x syndrome |
12/08/1994 | WO1994028171A1 Nucleic acid analogue assay procedures |
12/08/1994 | WO1994028170A1 Process for screening substances having a modulating effect on an interleukine-5-receptor-dependent cellular signal transmission path |
12/08/1994 | WO1994028163A1 Method for the determination of salmonella |
12/08/1994 | WO1994028161A1 Antibodies specific for dcc gene product |
12/08/1994 | WO1994028158A1 Antimucoglycoprotein monoclonal antibody |
12/08/1994 | WO1994028157A1 Fusion proteins containing adeno-associated virus rep protein and bacterial protein |
12/08/1994 | WO1994028154A1 Methods for increasing carbon conversion efficiency in microorganisms |
12/08/1994 | WO1994028153A2 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it |
12/08/1994 | WO1994028152A1 Defective adenoviruses and corresponding complementation lines |
12/08/1994 | WO1994028151A1 Gene therapy for haemophilia |
12/08/1994 | WO1994028150A1 Expression vectors responsive to steroid hormones |
12/08/1994 | WO1994028149A1 Method of improving the quality of stored potatoes |
12/08/1994 | WO1994028148A1 Genetic transformation method |
12/08/1994 | WO1994028147A1 Dna sequence comprising at least two coat protein genes |
12/08/1994 | WO1994028146A2 Dna sequences and plasmids for the preparation of sugar beet with changed sucrose concentration |
12/08/1994 | WO1994028145A2 Expression of urokinase plasminogen activator inhibitors |
12/08/1994 | WO1994028144A1 Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods |
12/08/1994 | WO1994028143A1 Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene |
12/08/1994 | WO1994028142A1 Putrescine n-methyltransferase, recombinant dna molecules encoding putrescine n-methyltransferase, and transgenic tobacco plants with decreased alkaloid content |
12/08/1994 | WO1994028141A1 Regulation of plant growth |
12/08/1994 | WO1994028140A1 Transgenic flowering plants |
12/08/1994 | WO1994028138A1 Multiple sclerosis virus |
12/08/1994 | WO1994028137A1 Regulator of contact-mediated hemolysin |
12/08/1994 | WO1994028136A2 Isolation of mushroom-inducing genes and their use in dna-mediated transformation of edible basidiomycetes |
12/08/1994 | WO1994028135A1 Process for activating gene expression in bacteria |
12/08/1994 | WO1994028134A1 Lymphocyte chemoattractant factor and uses thereof |
12/08/1994 | WO1994028133A1 Recombinant neu differentiation factors |
12/08/1994 | WO1994028132A2 Opioid receptors: compositions and methods |
12/08/1994 | WO1994028131A1 Dna encoding inward rectifier, g-protein activated, mammalian, potassium kga channel and uses thereof |
12/08/1994 | WO1994028130A1 Gene that codes for polypeptide having ability to support pre-b cell proliferation |
12/08/1994 | WO1994028129A2 Tumour metastasis gene |
12/08/1994 | WO1994028128A1 Test and model for polycystic ovary syndrome and male pattern baldness |
12/08/1994 | WO1994028127A1 Cancer treatment |
12/08/1994 | WO1994028126A2 Phenylalanine-free protein and dna coding therefor |
12/08/1994 | WO1994028125A2 Dna encoding prostaglandin receptor ep1 |
12/08/1994 | WO1994028124A1 Tnf alpha responsive element and tnf alpha induced dna-binding protein which binds to the tnf alpha responsive element |
12/08/1994 | WO1994028123A1 Mammals lacking expression of cd28 transgenic |
12/08/1994 | WO1994028122A1 Transgenic mammals lacking expression of particular cd45 isoforms |
12/08/1994 | WO1994028121A1 Non-human transgenic animal expressing a transferrin of human origin |
12/08/1994 | WO1994028117A1 Novel endoglucanase enzyme |
12/08/1994 | WO1994028116A1 Nucleic acid encoding amp-activated protein kinase |
12/08/1994 | WO1994028114A1 GENE INSERTION BY DIRECT LIGATION $i(IN VITRO) |
12/08/1994 | WO1994028113A1 Immortalization of denditric cells with v-myc oncogene |
12/08/1994 | WO1994028027A1 Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies |
12/08/1994 | WO1994028026A1 Genetically engineered immunoglobulins |
12/08/1994 | WO1994028025A1 Methods and compositions for inhibiting cd14 mediated cell activation |